Literature DB >> 23757402

Bimodal aldosterone distribution in low-renin hypertension.

E Victor Adlin1, Leonard E Braitman, Ramachandran S Vasan.   

Abstract

BACKGROUND: In low-renin hypertension (LRH), serum aldosterone levels are higher in those subjects with primary aldosteronism and may be lower in those with non-aldosterone mineralocorticoid excess or primary renal sodium retention. We investigated the hypothesis that the frequency distribution of aldosterone in LRH is bimodal.
METHODS: Of the 3,532 attendees at the sixth examination cycle of the Framingham Offspring Study, 1,831 were included in this cross-sectional analysis after we excluded those with conditions or taking medications such as antihypertensive drugs that might affect renin or aldosterone.
RESULTS: Three hundred three subjects (17%) had untreated hypertension (SBP ≥140 mm Hg or DBP ≥90 mm Hg). LRH, defined as plasma renin ≤5 mU/L, was present in 93 of those 303 hypertensive subjects (31%). Aldosterone values were adjusted statistically for age, sex, and the urinary sodium/creatinine ratio. In the subjects with LRH, the adjusted aldosterone distribution was bimodal (dip test for unimodality, P = 0.008). The adjusted aldosterone distribution was unimodal in the normal subjects (P = 0.98) and in the hypertensive subjects with normal plasma renin (P = 0.94).
CONCLUSIONS: In this community-based sample of white subjects, those with low-renin hypertension had a bimodal adjusted aldosterone distribution. Subjects with normal-renin hypertension and subjects with normal blood pressure had unimodal adjusted aldosterone distributions. These findings suggest 2 pathophysiological variants of LRH, one that is aldosterone-dependent and one that is non-aldosterone-dependent.

Entities:  

Keywords:  aldosterone; blood pressure; hypertension; low-renin hypertension; renin.

Mesh:

Substances:

Year:  2013        PMID: 23757402      PMCID: PMC3741228          DOI: 10.1093/ajh/hpt091

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  33 in total

Review 1.  Subtle acquired renal injury as a mechanism of salt-sensitive hypertension.

Authors:  Richard J Johnson; Jaime Herrera-Acosta; George F Schreiner; Bernardo Rodriguez-Iturbe
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

2.  PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM. IMPORTANCE IN DIFFERENTIAL DIAGNOSIS AND IN RESEARCH OF ESSENTIAL HYPERTENSION.

Authors:  J W CONN
Journal:  JAMA       Date:  1964-10-19       Impact factor: 56.272

3.  SUPPRESSION OF PLASMA RENIN ACTIVITY IN PRIMARY ALDOSTERONISM.

Authors:  J W CONN; E L COHEN; D R ROVNER
Journal:  JAMA       Date:  1964-10-19       Impact factor: 56.272

Review 4.  Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2004-02       Impact factor: 5.369

Review 5.  11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.

Authors:  P C White; T Mune; A K Agarwal
Journal:  Endocr Rev       Date:  1997-02       Impact factor: 19.871

6.  Alterations in aldosterone secretion and metabolism in low renin hypertension.

Authors:  G T Griffing; T E Wilson; J C Melby
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

7.  Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2.

Authors:  E Lovati; P Ferrari; B Dick; K Jostarndt; B M Frey; F J Frey; U Schorr; A M Sharma
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

8.  Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.

Authors:  Cristian A Carvajal; Damián G Romero; Lorena M Mosso; Alexis A González; Carmen Campino; Joaquín Montero; Carlos E Fardella
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

Review 9.  A genetic defect resulting in mild low-renin hypertension.

Authors:  R C Wilson; S Dave-Sharma; J Q Wei; V R Obeyesekere; K Li; P Ferrari; Z S Krozowski; C H Shackleton; L Bradlow; T Wiens; M I New
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

10.  Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients.

Authors:  Jana Henschkowski; Andreas E Stuck; Brigitte M Frey; Gerhard Gillmann; Bernhard Dick; Felix J Frey; Markus G Mohaupt
Journal:  Am J Hypertens       Date:  2008-04-03       Impact factor: 2.689

View more
  6 in total

Review 1.  70-year legacy of the Framingham Heart Study.

Authors:  Charlotte Andersson; Andrew D Johnson; Emelia J Benjamin; Daniel Levy; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2019-11       Impact factor: 32.419

2.  The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study.

Authors:  Jenifer M Brown; Cassianne Robinson-Cohen; Miguel Angel Luque-Fernandez; Matthew A Allison; Rene Baudrand; Joachim H Ix; Bryan Kestenbaum; Ian H de Boer; Anand Vaidya
Journal:  Ann Intern Med       Date:  2017-10-10       Impact factor: 25.391

3.  Association of Serum Aldosterone and Plasma Renin Activity With Ambulatory Blood Pressure in African Americans: The Jackson Heart Study.

Authors:  Joshua J Joseph; Neal K Pohlman; Songzhu Zhao; David Kline; Guy Brock; Justin B Echouffo-Tcheugui; Mario Sims; Valery S Effoe; Wen-Chih Wu; Rita R Kalyani; Gary S Wand; Bjorn Kluwe; Willa A Hsueh; Marwah Abdalla; Daichi Shimbo; Sherita H Golden
Journal:  Circulation       Date:  2021-02-19       Impact factor: 39.918

4.  The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs.

Authors:  J Martinez; C Kellogg; M C Iazbik; C G Couto; B M Pressler; T M Hoepf; M J Radin
Journal:  J Vet Intern Med       Date:  2017-05-09       Impact factor: 3.333

Review 5.  The Low-Renin Hypertension Phenotype: Genetics and the Role of the Mineralocorticoid Receptor.

Authors:  Rene Baudrand; Anand Vaidya
Journal:  Int J Mol Sci       Date:  2018-02-11       Impact factor: 5.923

Review 6.  Progress in the Management of Primary Aldosteronism.

Authors:  Ryo Morimoto; Kei Omata; Sadayoshi Ito; Fumitoshi Satoh
Journal:  Am J Hypertens       Date:  2018-04-13       Impact factor: 2.689

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.